我要投票 白敬宇在医疗用品行业中的票数:251
· 外 推 电 报 ·
2025-05-04 15:35:17 星期日

【白敬宇是哪个国家的品牌?】

白敬宇是什么牌子?「白敬宇」是 南京白敬宇制药有限责任公司 旗下著名品牌。该品牌发源于江苏,由创始人陈在1991-07-12期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力白敬宇品牌出海!将品牌入驻外推网,定制白敬宇品牌推广信息,可以显著提高白敬宇产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

南京白敬宇制药是一家生产化学原料药及制剂药的综合性制药公司,首批“中华老字号”和江苏省高新技术企业。公司前身“白敬宇眼药厂”1937年在南京成立,“白敬宇”商标于1939年注册,是中国为数极少的民国时期药品注册商标之一,2011年被国家工商总局认定为“中国驰名商标”。公司现有员工近800人,近三年累计产销和利税分别为12.67亿元和1.16亿元,2012年在岗员工人均可支配收入6.22万元。

公司原料药和制剂药生产基地分别位于六合化学工业园区和新港经济技术开发区,两个厂区绿树成荫,均为园区的“园林式工厂”,在2010-2011年先后通过了ISO9001质量体系认证、ISO14001环境管理体系认证以及ISO18001职业健康安全管理体系的认证,在同类企业中处于领先地位。

公司现有注册产品120个,其中原料药27个,制剂药93个。制剂药有片剂、膏剂、胶囊剂、散剂、酊剂、混悬液剂、凝胶剂等15个剂型,主要产品有心脑血管、祛痰镇咳、抗感染、维生素类、眼用膏剂等系列品种,有26个产品进入国家基本药物目录。主要剂型的年最大产量为:片剂80亿片,激素药20亿片,酊水100万升,膏剂6500万支,胶囊剂6.5亿粒,混悬剂45万升、洗剂5万升、散剂9000万包。公司另有24个品规的制剂药产品在12个国家取得了药品注册证书,产品销售到38个国家和地区。公司原料药常年生产盐酸左旋咪唑、酮康唑、氯霉素及酮酸钙等产品,年生产能力大于1000吨。原料药3个主要品种已在欧洲、美国、日本、俄罗斯等国注册销售。

公司的“国际合作”理念决定了公司对原料生产区的环保治理具有超前意识,按照国际惯例,客户在接受产品前必须对企业进行严格的全面质量审计,其中“人的安全和环境保护”是审计的重要项目,因此,供应商审计是公司能够不断进步的动力。2006年至今,原料药厂区共接受国外供应商审计20余次,其中有美国通用、比利时杨森、德国拜耳、西班牙因杜肯等国际性大公司,公司现已成为上述公司的产品供应商。

公司是南京市药品出口产量最大的企业,尤其是制剂药出口更是领先,自营出口1千万美元,出口供货值1亿元人民币。公司以“做好产品、卖好产品”为宗旨,致力于实业拓展。公司的目标是:到2014年,产品制造水平要达到国内一流、国际中等以上标准,以满足不同市场的客户需要,确保企业可持续发展。

英文翻译:Nanjing Baijingyu Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company that produces chemical raw materials and pharmaceutical preparations. It is one of the first batch of "Chinese time-honored brands" and high-tech enterprises in Jiangsu Province. The company's predecessor, Bai Jingyu eye pharmaceutical factory, was established in Nanjing in 1937. The trademark of Bai Jingyu was registered in 1939. It is one of the few drug registered trademarks in the Republic of China. In 2011, it was recognized as "China's famous trademark" by the State Administration of industry and Commerce. The company has nearly 800 employees. In the past three years, the cumulative production and sales and profits and taxes are RMB 1.267 billion and RMB 116 million respectively. In 2012, the average disposable income of on-the-job employees is RMB 62200. The company's API and pharmaceutical production bases are respectively located in Liuhe chemical industry park and Xingang economic and Technological Development Zone. Both of the two plants are "garden type factories" in the park. From 2010 to 2011, they have passed ISO9001 quality system certification, ISO14001 environmental management system certification and ISO18001 occupational health and safety management system certification, and are in the leading position among similar enterprises First place. The company has 120 registered products, including 27 APIs and 93 pharmaceutical preparations. Preparations include tablets, ointments, capsules, powder, tincture, suspension, gel and other 15 formulations. The main products are cardiovascular, expectorant, antitussive, anti infective, vitamin, eye paste and other varieties. 26 products have entered the national essential drug list. The annual maximum production of main dosage forms is: 8 billion tablets, 2 billion hormone drugs, 1 million liters tincture water, 65 million plasters, 650 million capsules, 450000 liters suspension, 50000 liters lotion and 90 million packages powder. Another 24 pharmaceutical products of the company have obtained drug registration certificates in 12 countries, and the products have been sold to 38 countries and regions. The company's APIs produce levamisole hydrochloride, ketoconazole, chloramphenicol, calcium ketoacid and other products throughout the year, with an annual production capacity of more than 1000 tons. Three main varieties of APIs have been registered and sold in Europe, the United States, Japan, Russia and other countries. The company's concept of "international cooperation" determines that the company has an advanced awareness of environmental protection in the raw material production area. According to international practice, customers must conduct a strict overall quality audit on the enterprise before accepting products. Among them, "human safety and environmental protection" is an important audit project. Therefore, supplier audit is the driving force for the company to make continuous progress. Since 2006, the API plant area has been audited by foreign suppliers for more than 20 times, among which there are international large companies such as general motors of the United States, Janssen of Belgium, Bayer of Germany, induken of Spain, etc. the company has become the product supplier of the above companies. The company is the largest pharmaceutical export enterprise in Nanjing, especially the leading pharmaceutical export, with self export of US $10 million and export supply value of RMB 100 million. With the tenet of "do well in products and sell well in products", the company is committed to industrial development. The company's goal is: by 2014, the product manufacturing level should reach the domestic first-class, international medium-sized and above standards, so as to meet the needs of customers in different markets and ensure the sustainable development of the enterprise.

本文链接: https://www.waitui.com/brand/ba0510fe3.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

投票通过,马斯克的星舰基地成了一座“真正的”城镇

美国太空探索技术公司(SpaceX)火箭制造与发射基地所在的得克萨斯州南部墨西哥湾沿岸地区于5月3日投票,决定是否将当地升级为一座名为“星舰基地”的城镇。目前,有173票赞成,4票反对。只需143票赞成就算通过,“星舰基地”成为城镇已成定局。太空探索技术公司首席执行官埃隆·马斯克在社交媒体发文:“得克萨斯的星舰基地,现在是一座真正的城市了!”。太空探索技术公司的火箭制造与发射基地位于得州南部的博卡奇卡,面积仅3.9平方公里,靠近美国与墨西哥边境。公司首席执行官埃隆·马斯克2021年最初提出在此建立城镇的想法。对该投票,太空探索技术公司未予置评,公司高层先前也未解释为何要建立这样一座企业城镇。(央视新闻)

2小时前

全国出行客流持续高位运行,公路迎来返程车流

今天是“五一”假期的第四天,客流继续保持高位运行。公路迎来返程车流。今天全国铁路预计发送旅客2040万人次,计划加开列车1818列。客流较昨日有明显增长,继续保持高位运行。多地增开赏花高铁、夜间高铁等,同时根据客流情况增加人工检票口和进站安检通道,减少旅客的等候时间。公路出行方面,中长途返程车流与短途返城车流叠加,返程高峰显现,预计今天16—18点将出现返程车流量大现象。(央视新闻)

2小时前

天津物美超市学习胖东来自主调改

继天津永辉学习胖东来调改后,物美超市也加入调改队伍。5月1日,物美超市官方正式发布《学习胖东来自主调改的说明》,天津首家调改店定在物美超市北辰店。(今晚报)

2小时前

铁路迎来返程高峰,今日北京地区预计到达旅客75.8万人次

今日铁路迎来返程客流高峰,记者从国铁集团获悉,5月4日,全国铁路预计发送旅客2040万人次,计划加开旅客列车1818列。北京地区预计发送63.4万人次、到达75.8万人次,计划增开旅客列车60对,主要开往上海、武汉、沈阳、济南、青岛、太原、天津、石家庄、张家口等方向。(北京日报)

2小时前

“英伟达已向中国三家企业通报”

据台湾《工商时报》网站5月3日报道,在针对中国市场的H20芯片遭美国政府禁售后,美国芯片大厂英伟达正加紧开发另一款符合美国出口规定的人工智能(AI)芯片,以继续保住其在中国的市场份额。据美媒报道,英伟达已向中国三家企业通报,正调整AI芯片设计,寻求在不触犯美国出口管制的前提下,继续向中国供应产品。(参考消息)

2小时前

本页详细列出关于白敬宇的品牌信息,含品牌所属公司介绍,白敬宇所处行业的品牌地位及优势。
咨询